We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Integrated Diagnostics Holdings Plc | LSE:IDHC | London | Ordinary Share | JE00BLKGSR75 | ORD USD0.25 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.0005 | -0.14% | 0.3445 | 0.34 | 0.349 | 0.34 | 0.34 | 0.34 | 31,042 | 16:35:07 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMIDHC
RNS Number : 1881Z
Integrated Diagnostics Holdings PLC
10 March 2017
For filings with the FCA include the annex For filings with issuer exclude the annex TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i) --------------------------------------------------------------------------------------------- 1. Identity of the issuer or INTEGRATED DIAGNOSTICS the underlying issuer HOLDINGS PLC of existing shares to which voting rights are attached: (ii) ----------------------------------------------------------- -------------------------------- 2 Reason for the notification (please tick the appropriate box or boxes): --------------------------------------------------------------------------------------------- An acquisition or disposal of voting rights X ------------------------------------------------------------ ------------------------------- An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached ------------------------------------------------------------ ------------------------------- An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments ------------------------------------------------------------ ------------------------------- An event changing the breakdown of voting rights ------------------------------------------------------------ ------------------------------- Other (please specify): ---------------------------------------------------------- ------------------------------- 3. Full name of person(s) T. Rowe Price Associates, subject to the Inc. notification obligation: (iii) ----------------------------------------------------------- -------------------------------- 4. Full name of shareholder(s) JP Morgan Chase (if different from 3.):(iv) Bank of New York Mellon Bank, N.A. Northern Trust Co. ----------------------------------------------------------- -------------------------------- 5. Date of the transaction 08 March 2017 and date on which the threshold is crossed or reached: (v) ----------------------------------------------------------- -------------------------------- 6. Date on which issuer 10 March 2017 notified: ----------------------------------------------------------- -------------------------------- 7. Threshold(s) that is/are crossed or reached: (vi, vii) 5% ----------------------------------------------------------- -------------------------------- 8. Notified details: ---------------------------------------------------------------------------------------------------------------------- A: Voting rights attached to shares (viii, ix) ---------------------------------------------------------------------------------------------------------------------- Class/type Situation previous Resulting situation after the of to the triggering triggering transaction shares transaction if possible using the ISIN CODE ------------- ---------------------------------- ------------------------------------------------------------------- Number Number Number Number of % of voting of of of shares voting rights (x) Shares Voting rights Rights ------------- ---------------- ---------------- -------------- ------------------------ ------------------------- Direct Direct Indirect Direct Indirect (xi) (xii) ------------- ------------ ------------ -------------- --------- ------------- ------------ ----------- JE00BV9H9G76 7,474,850 7,474,850 7,570,134 7,570,134 5.04% ---------------- ---------------- -------------- --------- ------------- ------------ ----------- B: Qualifying Financial Instruments ---------------------------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ---------------------------------------------------------------------------------------------------------------------- Type of Expiration Exercise/ Number of voting % of voting financial date Conversion rights that rights instrument (xiii) Period (xiv) may be acquired if the instrument is exercised/ converted. ----------------- -------------- -------------------------------- -------------------------- --------------------- C: Financial Instruments with similar economic effect to Qualifying Financial Instruments (xv, xvi) ---------------------------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ---------------------------------------------------------------------------------------------------------------------- Type of Exercise Expiration Exercise/ Number of voting % of voting financial price date Conversion rights instrument rights (xix, instrument (xvii) period refers to xx) (xviii) --------------- -------------- -------------- ---------------- -------------------------- ----------------------- Nominal Delta --------------- -------------- -------------- ---------------- -------------------------- ------------ --------- Total (A+B+C) ---------------------------------------------------------------------------------------------------------------------- Number of voting rights Percentage of voting rights --------------------------------------------------- ----------------------------------------------------------------- 7,570,134 5.04% --------------------------------------------------- ----------------------------------------------------------------- 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: (xxi) ------------------------------------------------------------------------------------------ T. Rowe Price Associates, Inc. (TRPA) serves as investment adviser, with dispositive and voting authority, to various institutional clients that own shares of Integrated Diagnostics Holding Plc., including the T. Rowe Price International Discovery Fund, which owns 5,391,836 shares. Such shares are registered in the following name(s): Bank of New York Mellon Bank, N.A. - 337,429 JP Morgan Chase - 7,172,393 Northern Trust Co. - 60,312 Proxy Voting: ------------------------------------------------------------------------------------------ 10. Name of the proxy holder: ------------------------------------------------------------- --------------------------- 11. Number of voting rights proxy holder will cease to hold: ------------------------------------------------------------- --------------------------- 12. Date on which proxy holder will cease to hold voting rights: ------------------------------------------------------------- --------------------------- 13. Additional information: ------------------------------------------------------------- --------------------------- 14. Contact name: Gary Greb, Vice President T. Rowe Price Associates, Inc. ------------------------------------------------------------- --------------------------- 15. Contact telephone number: 001 410 345 2527 ------------------------------------------------------------- ---------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLURVSRBSAOAAR
(END) Dow Jones Newswires
March 10, 2017 09:55 ET (14:55 GMT)
1 Year Integrated Diagnostics Chart |
1 Month Integrated Diagnostics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions